Potential compounder with a catalyst?

New CEO + margin expansion + potential 0 revenue asset monetization

The stock I have today, Immucell (ICCC), has both long term compounder potential and could also qualify as somewhat of a special situation (0 revenue asset monetization). Gross margins have been decl…